Great Lakes Advisors LLC Takes $702,000 Position in Agilon Health, Inc. $AGL

Great Lakes Advisors LLC acquired a new stake in Agilon Health, Inc. (NYSE:AGL) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 6,549 shares of the company’s stock, valued at approximately $702,000.

A number of other hedge funds also recently added to or reduced their stakes in AGL. Bank of New York Mellon Corp grew its holdings in Agilon Health by 9.5% during the 2nd quarter. Bank of New York Mellon Corp now owns 35,336 shares of the company’s stock worth $3,787,000 after acquiring an additional 3,074 shares in the last quarter. Alpine Global Management LLC bought a new stake in shares of Agilon Health in the 4th quarter valued at about $84,000. Invesco Ltd. raised its holdings in shares of Agilon Health by 30.7% in the 4th quarter. Invesco Ltd. now owns 1,004,266 shares of the company’s stock valued at $692,000 after purchasing an additional 235,951 shares in the last quarter. Mercer Global Advisors Inc. ADV purchased a new stake in shares of Agilon Health in the 4th quarter worth approximately $86,000. Finally, Numerai GP LLC lifted its position in shares of Agilon Health by 207.3% in the 4th quarter. Numerai GP LLC now owns 1,228,071 shares of the company’s stock worth $846,000 after purchasing an additional 828,472 shares during the period.

Analysts Set New Price Targets

A number of research firms have recently issued reports on AGL. Jefferies Financial Group upgraded shares of Agilon Health from a “hold” rating to a “buy” rating and increased their price objective for the company from $27.50 to $48.00 in a research note on Thursday, May 7th. Wells Fargo & Company reissued an “overweight” rating and issued a $146.00 price objective (up from $141.00) on shares of Agilon Health in a research note on Tuesday, August 11th. Wall Street Zen upgraded Agilon Health from a “sell” rating to a “hold” rating in a report on Saturday, May 9th. Robert W. Baird set a $116.00 target price on Agilon Health in a research report on Thursday, August 6th. Finally, Truist Financial set a $112.00 price target on Agilon Health and gave the company a “hold” rating in a report on Thursday, August 6th. Five analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $91.30.

Agilon Health Stock Performance

Shares of Agilon Health stock opened at $96.32 on Friday. The company has a market capitalization of $1.62 billion, a PE ratio of -6.75 and a beta of 3.01. The company has a 50-day simple moving average of $105.84 and a two-hundred day simple moving average of $60.88. Agilon Health, Inc. has a one year low of $7.48 and a one year high of $133.04. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.08 and a current ratio of 1.08.

Agilon Health (NYSE:AGL) last released its quarterly earnings results on Wednesday, August 5th. The company reported $1.04 earnings per share for the quarter, beating analysts’ consensus estimates of $0.14 by $0.90. Agilon Health had a negative net margin of 3.92% and a negative return on equity of 119.38%. The business had revenue of $1.49 billion for the quarter, compared to analysts’ expectations of $1.45 billion. Research analysts expect that Agilon Health, Inc. will post -2.95 EPS for the current fiscal year.

About Agilon Health

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.